Pain News and Research

Latest Pain News and Research

Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Chemists at the University of Leicester have reported a breakthrough in techniques to develop new drugs in the fight against diseases such as cancer and Alzheimer's.

24 Sep 2014

Teens around the world frequently use OTC and prescription medications without doctor's order

Adolescents around the world are frequently using over-the-counter and prescription medications without a doctor's order, a risky practice that can lead to overuse and abuse and is often continued into adulthood, reveals a new review in the Journal of Adolescent Health.

24 Sep 2014

Desaturation 'area under the curve' may help in monitoring patient safety during procedures

The "area under the curve of oxygen desaturation" (AUCDesat) may provide a more sophisticated approach to monitoring blood oxygen levels during procedures using sedation, according to a study published in Anesthesia & Analgesia.

24 Sep 2014

Epidurals and reduced postpartum depression: an interview with Dr. Zakowski

The “maternity blues”, which resolve within 10 days of giving birth, occurs in up to 80% of new moms. A major depressive episode, by Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria, is defined as having at least a 2-week period of persistent depressed mood ...

23 Sep 2014

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen)

23 Sep 2014

Young scientists from European member country invited to apply for EFIC-Grünenthal Grant 2014

Young scientists from any European member country of the European Pain Federation EFIC® are invited to apply for the EFIC-Grünenthal Grant (E-G-G) 2014.

23 Sep 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai physicians and scientists are testing a novel, human cell based, bioartificial liver support system for patients with acute liver failure, often a fatal diagnosis.

23 Sep 2014

New evidence-based guidelines for prevention, treatment of POAF

The American Association for Thoracic Surgery has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation (POAF) and flutter for thoracic surgical procedures.

23 Sep 2014

Pilot study shows benefits of psychoeducational wellness program in MS people

Kessler researchers have published a pilot study showing the benefits of a 10-week psychoeducational wellness program in people with multiple sclerosis (MS). Improvements were seen in mood, overall mental health, perceived stress, and pain.

23 Sep 2014

Single-family room environment can optimize care for preterm infants

The prevalence of preterm birth - the birth of an infant prior to 37 weeks of pregnancy - is a significant health problem that has increased over the past two decades. According to the Centers for Disease Control and Prevention, preterm birth affects nearly 500,000 babies each year, or one of every eight born in the U.S. While medical care has improved survival rates for preterm infants, questions remain about ways to positively impact the neurodevelopmental outcomes of preterm infants.

23 Sep 2014

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).

23 Sep 2014

Neuropathic pain phenotype identified in knee osteoarthritis

Some patients with knee osteoarthritis may experience neuropathic-like symptoms associated with central pain processing, reflecting a discrete phenotype, study findings suggest.

22 Sep 2014

EYLEA Injection gets approval in Japan for treatment of myopic CNV

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEA (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV).

22 Sep 2014

UVA earns national award for enhancing care for heart attack patients

The University of Virginia Health System has earned a national award from the American College of Cardiology for enhancing care for heart attack patients.

21 Sep 2014

Researchers identify control mechanism for mood disorders

Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."

19 Sep 2014

Health law's ripple effects on hospitals, schools, uninsured

The Kansas City Star reports that some uninsured patients fall through the cracks as hospitals cut back on charity care to persuade people to sign up for coverage. Some schools, meanwhile, are turning to private substitutes to avoid having to pay for their health coverage next year. In Colorado, Denver Health is back in the black, partly due to a dramatic decrease in uninsured patients.

19 Sep 2014

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked by ear pain, pressure and dulled hearing.

18 Sep 2014

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).

18 Sep 2014

Benefits and risks of hatha yoga for people with bipolar disorder

Right now no one can say whether yoga provides clinical benefits to people with bipolar disorder, but in a new article in the Journal of Psychiatric Practice, researchers report survey responses they gathered from scores of people with the condition who practice yoga. What the collective testimony suggests is that yoga can be a substantial help, but it sometimes carries risks, too.

18 Sep 2014

Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor could be a useful biomarker for the diagnosis of overactive bladder and a predictive biomarker to help guide treatment, Chinese researchers believe.

17 Sep 2014

Pain News and Research

Latest Pain News and Research

Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Teens around the world frequently use OTC and prescription medications without doctor's order

Desaturation 'area under the curve' may help in monitoring patient safety during procedures

Epidurals and reduced postpartum depression: an interview with Dr. Zakowski

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

Young scientists from European member country invited to apply for EFIC-Grünenthal Grant 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

New evidence-based guidelines for prevention, treatment of POAF

Pilot study shows benefits of psychoeducational wellness program in MS people

Single-family room environment can optimize care for preterm infants

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Neuropathic pain phenotype identified in knee osteoarthritis

EYLEA Injection gets approval in Japan for treatment of myopic CNV

UVA earns national award for enhancing care for heart attack patients

Researchers identify control mechanism for mood disorders

Health law's ripple effects on hospitals, schools, uninsured

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Benefits and risks of hatha yoga for people with bipolar disorder

Urinary nerve growth factor shows diagnostic value

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in